Antimicrobials for diabetic foot infections
Clinical design of trials for antimicrobials intended for the treatment of diabetic foot infections will be a topic of FDA's Anti-Infective Drugs Advisory Committee on Oct. 28. The committee will meet in closed session from 8 a.m. to 12 p.m., and the discussion on diabetic infections will begin at 1 p.m...
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.